Dakota Wealth Management Abb Vie Inc. Transaction History

Dakota Wealth Management

$4.35 Billion
Q3 2024

A detailed history of Dakota Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Dakota Wealth Management holds 40,988 shares of ABBV stock, worth $7.25 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

40,988

Previous 39,997 2.48%

Holding current value

$7.25 Million

Previous $6.86 Million 17.99%

% of portfolio

0.19%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $162,365 - $197,536	991 Added 2.48%	40,988 $8.09 Million
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $35,137 - $41,032	-227 Reduced 0.56%	39,997 $6.86 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $3.44 Million - $3.92 Million	21,553 Added 115.44%	40,224 $7.32 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $422,156 - $475,447	-3,068 Reduced 14.11%	18,671 $2.89 Million
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $156,433 - $181,095	1,171 Added 5.69%	21,739 $3.24 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $3.46 Million - $4.31 Million	-26,144 Reduced 55.97%	20,568 $2.77 Million
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $3.07 Million - $3.54 Million	-21,264 Reduced 31.28%	46,712 $7.44 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $1.23 Million - $1.47 Million	8,867 Added 15.0%	67,976 $11 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $4.11 Million - $4.72 Million	30,638 Added 107.61%	59,109 $7.93 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $148,354 - $188,606	-1,078 Reduced 3.65%	28,471 $4.36 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $501,523 - $622,250	3,800 Added 14.76%	29,549 $4.79 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $204,761 - $259,082	1,906 Added 7.99%	25,749 $3.49 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $5.25 Million - $5.96 Million	-49,357 Reduced 67.43%	23,843 $2.57 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $5.12 Million - $5.7 Million	48,669 Added 198.4%	73,200 $8.25 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $1.41 Million - $1.56 Million	13,828 Added 129.2%	24,531 $2.66 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $4.83 Million - $6.52 Million	-59,959 Reduced 84.85%	10,703 $1.15 Million
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $3.28 Million - $3.85 Million	-38,225 Reduced 35.11%	70,662 $6.19 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $1.22 Million - $1.63 Million	16,618 Added 18.01%	108,887 $10.7 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $1.31 Million - $1.99 Million	20,375 Added 28.34%	92,269 $7.03 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $3.07 Million - $3.84 Million	42,499 Added 144.58%	71,894 $6.37 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.85 Million - $2.23 Million	29,395 New	29,395 $2.23 Million
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $1.01 Million - $1.19 Million	-13,078 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $38,925 - $48,005	500 Added 3.98%	13,078 $1.24 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $255,527 - $284,066	-2,874 Reduced 18.6%	12,578 $1.19 Million
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $1.04 Million - $1.23 Million	11,554 Added 296.41%	15,452 $1.43 Million
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $95,690 - $128,138	1,040 Added 36.39%	3,898 $369,000
Q4 2017 Jan 16, 2018	BUY	$89.56 - $98.21 $255,962 - $280,684	2,858	2,858 $276,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.

Account

Dakota Wealth Management Abb Vie Inc. Transaction History